{"organizations": [], "uuid": "746df1d12f82df50ddfd3702d954148b3ee70a1b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mithra-pharmaceuticals-announces-l/brief-mithra-pharmaceuticals-announces-last-subject-completes-donesta-phase-ii-study-idUSFWN1PK03K", "country": "US", "domain_rank": 408, "title": "BRIEF-Mithra Pharmaceuticals Announces Last Subject Completes Donesta Phase II Study​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.022, "site_type": "news", "published": "2018-01-25T17:21:00.000+02:00", "replies_count": 0, "uuid": "746df1d12f82df50ddfd3702d954148b3ee70a1b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mithra-pharmaceuticals-announces-l/brief-mithra-pharmaceuticals-announces-last-subject-completes-donesta-phase-ii-study-idUSFWN1PK03K", "ord_in_thread": 0, "title": "BRIEF-Mithra Pharmaceuticals Announces Last Subject Completes Donesta Phase II Study​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - MITHRA PHARMACEUTICALS SA:\n* ‍MITHRA ANNOUNCES LAST SUBJECT COMPLETES DONESTA® PHASE II STUDY​\n* ‍PHASE II STUDY ON TRACK TO YIELD TOP LINE DATA LATE Q1 2018​\n* ‍260 WOMEN RECRUITED, OVER 200 COMPLETED AT LEAST 12 WEEKS OF TREATMENT IN PHASE II STUDY​\n* ‍12-WEEK DATA GENERATED FOR ADDITIONAL 15% OF SUBJECTS TO IMPROVE ROBUSTNESS OF ANALYSIS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-25T17:21:00.000+02:00", "crawled": "2018-01-26T21:30:47.026+02:00", "highlightTitle": ""}